During the past decade, Irkutsk State Medical Academy of Continuing Education conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 7 clinical trials were completed, i.e. on average, 43.8% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 6 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Irkutsk State Medical Academy of Continuing Education" #1 sponsor was "Celgene" with 5 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Eli Lilly and Company" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Irkutsk State Medical Academy of Continuing Education" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Irkutsk State Medical Academy of Continuing Education" are "Crohn Disease" (8 trials), "Ulcerative Colitis" (7 trials), "Elective Colonoscopy" (1 trials), "Hepatitis B, Chronic" (1 trials) and "Hepatitis D, Chronic" (1 trials). Many other conditions were trialed in "Irkutsk State Medical Academy of Continuing Education" in a lesser frequency.

Most popular intervention types in "Irkutsk State Medical Academy of Continuing Education" are "Drug" (17 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Etrolizumab" (4 trials), "Etrasimod" (3 trials), "Ozanimod" (3 trials) and "JNJ-73763989" (2 trials). Other intervention names were less common.

The vast majority of trials in "Irkutsk State Medical Academy of Continuing Education" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Irkutsk State Medical Academy of Continuing Education". undefined are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Irkutsk State Medical Academy of Continuing Education, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Irkutsk State Medical Academy of Continuing Education, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".